UFP Technologies, Inc.

UFPT ·Healthcare, Medical Devices, United States
Financial Statements Income Statement
Annual Quarterly

Income Statement

Line Item FY2026 FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019
Revenue $602.8M $504.4M $400.1M $353.8M $206.3M $179.4M $198.4M
Cost of Revenue $432.4M $357.7M $287.8M $263.5M $155.2M $134.7M $144.4M
Gross Profit $170.4M $146.7M $112.2M $90.3M $51.1M $44.7M $54.0M
Gross Margin 28.3% 29.1% 28.1% 25.5% 24.8% 24.9% 27.2%
Operating Expenses
Research & Development $8.6M $10.4M $7.2M $9.3M $8.5M $8.2M $8.8M
SG&A Expense $77.4M $62.2M $50.9M $45.8M $29.5M $27.5M $29.3M
Operating Income $92.3M $80.9M $57.7M $55.4M $21.2M $16.7M $24.7M
Operating Margin 15.3% 16.0% 14.4% 15.7% 10.3% 9.3% 12.5%
Interest Expense $8.1M $3.6M $2.8M $39.0K $83.0K $674.0K
Pretax Income $82.5M $73.0M $53.9M $52.7M $21.2M $16.3M $23.6M
Income Tax Expense $14.2M $14.0M $9.0M $10.9M $5.3M $2.9M $3.9M
Net Income $68.3M $59.0M $44.9M $41.8M $15.9M $13.4M $19.8M
Net Margin 11.3% 11.7% 11.2% 11.8% 7.7% 7.5% 10.0%
EPS (Basic) $8.87 $7.69 $5.89 $5.52 $2.11 $1.79 $2.66
EPS (Diluted) $8.75 $7.58 $5.83 $5.45 $2.09 $1.77 $2.63
Shares Outstanding (Basic) 7.7M 7.7M 7.7M 7.6M 7.6M 7.5M 7.5M 7.4M
Shares Outstanding (Diluted) 7.7M 7.8M 7.8M 7.7M 7.7M 7.6M 7.6M 7.5M
Dividends Per Share
← Newer Page 1 of 3 Older →